Chi Han Li Selected Research

Chi Han Li Research Topics

8	Neoplasms (Cancer) 01/2022 - 05/2013
3	Adenocarcinoma 01/2020 - 05/2013
2	Hepatocellular Carcinoma (Hepatoma) 01/2019 - 10/2014
1	Neoplasm Metastasis (Metastasis) 01/2022
1	Hyperlipidemias (Hyperlipidemia) 04/2018
1	Inflammation (Inflammations) 04/2018
1	Non-alcoholic Fatty Liver Disease 04/2018
1	Insulin Resistance 04/2018
1	Endotoxemia 09/2007
1	Hypoxia (Hypoxemia) 09/2007
1	Sepsis (Septicemia) 09/2007

4	Long Noncoding RNAIBA 01/2022 - 08/2013
3	Proteins (Proteins, Gene)FDA Link 01/2019 - 05/2013
3	MicroRNAs (MicroRNA)IBA 04/2018 - 10/2014
2	RNA (Ribonucleic Acid)IBA 01/2022 - 08/2013
2	Histone MethyltransferasesIBA 01/2019 - 05/2013
1	histone H3 trimethyl Lys4IBA 01/2022
1	Antisense RNA (Anti-Sense RNA)IBA 01/2022
1	Serine (L-Serine)FDA Link 01/2022
1	RNA Polymerase II (RNA Polymerase B)IBA 01/2022
1	Mitogen-Activated Protein Kinase 1 (p42 MAP Kinase)IBA 01/2020
1	Gemcitabine FDA Link 01/2020
1	Therapeutic UsesIBA 04/2018
1	BerberineIBA 04/2018
1	2'- hydroxy- 2,4,4',5,6'- pentamethylchalconeIBA 11/2014
1	Sorafenib (BAY 43-9006)FDA Link 11/2014
1	Antineoplastic Agents (Antineoplastics)IBA 11/2014
1	Interleukin-6 (Interleukin 6)IBA 10/2014
1	hepatitis B virus X proteinIBA 10/2014
1	16-iodo-3-methylhexadecanoic acid (MIHA)IBA 10/2014
1	ellagitanninIBA 01/2014
1	davidiinIBA 01/2014
1	Antisense OligonucleotidesIBA 08/2013
1	Untranslated RNA (Noncoding RNA)IBA 08/2013
1	Uridine Diphosphate (UDP)IBA 05/2013
1	GlycosyltransferasesIBA 05/2013
1	Enhancer of Zeste Homolog 2 ProteinIBA 05/2013
1	HeterochromatinIBA 05/2013
1	Messenger RNA (mRNA)IBA 05/2013
1	Deferoxamine (Desferal)FDA LinkGeneric 09/2007
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 09/2007
1	Pentobarbital (Nembutal)FDA Link 09/2007

2	Therapeutics 01/2022 - 08/2013
1	Critical Care (Surgical Intensive Care) 09/2007